Bollard Group LLC Astrazeneca PLC Transaction History

Bollard Group LLC

$3.61 Billion
Q4 2024

A detailed history of Bollard Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Bollard Group LLC holds 1,510 shares of AZN stock, worth $111,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,510

Previous 1,510 -0.0%

Holding current value

$111,105

Previous $118,000 16.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $690 - $788	9 Added 0.6%	1,510 $118,000
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $1,342 - $1,530	22 Added 1.49%	1,501 $102,000
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $648 - $717	10 Added 0.68%	1,479 $100,000
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $36,912 - $40,027	528 Added 56.11%	1,469 $105,000
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $820 - $930	13 Added 1.4%	941 $65,000
Q3 2022 Nov 09, 2022	BUY	$53.02 - $135.75 $371 - $950	7 Added 0.76%	928 $51,000
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $780 - $939	14 Added 1.54%	921 $61,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $50,392 - $55,136	907 New	907 $54,000
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $1.89 Million - $2.15 Million	-47,188 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$35.49 - $43.02 $35,702 - $43,278	1,006 Added 2.18%	47,188 $1.91 Million
Q3 2018 Nov 08, 2018	BUY	$34.76 - $39.72 $18,388 - $21,011	529 Added 1.16%	46,182 $1.83 Million
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $39,135 - $43,479	1,187 Added 2.67%	45,653 $1.6 Million
Q3 2017 Oct 27, 2017	BUY	$28.96 - $34.0 $1.29 Million - $1.51 Million	44,466	44,466 $1.51 Million

Others Institutions Holding AZN

# of Institutions

1,351

Shares Held

489M

Call Options Held

5.88M

Put Options Held

4.1M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Account

Bollard Group LLC Astrazeneca PLC Transaction History